Results 191 to 200 of about 50,141 (259)

Analyzing real-world adverse events of spironolactone with the FAERS database. [PDF]

PLoS One
Lin G, Chen R, Wen C, Li Z, Yan X, Li L.
europepmc   +1 more source

Efficacy and Safety of Oral Spironolactone for Women With Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials With Trial Sequential Analysis. [PDF]

J Cosmet Dermatol
Ghanem L, Kirmani N, De León Fernández N, Palacios-Ortiz MP, Rodríguez-Parra JD, Rusu CA.   +5 more
europepmc   +1 more source

Spironolactone Targets Retinoid X Receptor γ to Promote Myelin Sheath Regeneration. [PDF]

Neurol Neuroimmunol Neuroinflamm
Sun QQ, Ai RS, Chai NN, Han B, Bao MY, Li YB, Ma GX, Wang LJ, Qian ZQ, Li X, Zhang Y.   +10 more
europepmc   +1 more source

Identification of non-oncology drugs with activity against inflammatory and triple-negative breast cancer cell lines. [PDF]

Oncol Lett
Ahmad S, Kandil S, Williams KP, Scott JE.   +3 more
europepmc   +1 more source

Effect of spironolactone on cardiovascular and renal outcomes in patients with chronic kidney disease. [PDF]

Clin Kidney J
Chen TH, Ou SM, Lin KH, Ho Y, Tseng WC, Chu YC, Tarng DC.   +6 more
europepmc   +1 more source

Combining spironolactone to antiretroviral therapy accelerates HIV decay in humanized mice. [PDF]

Emerg Microbes Infect
Ling L, Mori LP, Soper A, Yao W, McAuley AT, Leda AR, Spagnuolo RA, Begum N, Kovarova M, Wahl A, Cameron MD, Valente ST, Garcia JV.   +12 more
europepmc   +1 more source

Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy

, 2017
Güler Yavaş, Zeliha Esin Çelik, Çağdaş Yavaş, Çağdaş Elsürer, Rengin Elsürer Afşar   +4 more
openalex   +1 more source

Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study. [PDF]

ESC Heart Fail
Hutten CG, Tekumulla A, Ismail A, Vasbinder A, Farhat T, Kunkle P, Goonewardena SN, Abdel-Latif A, Pitt B, Hayek SS.   +9 more
europepmc   +1 more source

No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study [PDF]

Rachel C. Hill, Yu Wang, Bilal Shaikh, Shari R. Lipner   +3 more
openalex   +1 more source

Rifampicin-induced challenges in managing endocrine hypertension and primary aldosteronism: a case report and literature review. [PDF]

Front Pharmacol
Song X, Jia M, Yu H, Dong Z, Cheok K, Pan X.   +5 more
europepmc   +1 more source